Renaissance Technologies LLC 13D and 13G filings for Opiant Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-02-11 09:32 am Sale |
2021-12-31 | 13G | Opiant Pharmaceuticals, Inc. OPNT |
Renaissance Technologies LLC | 183,815 3.890% |
-53,000 (-22.38%) |
Filing |
| 2021-02-10 4:09 pm Purchase |
2020-07-17 | 13G | Opiant Pharmaceuticals, Inc. OPNT |
Renaissance Technologies LLC | 236,815 5.560% |
236,815 (New Position) |
Filing |